Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Ophthalmology | Family Medicine

Ocular Hypertension Clinical Trials


A listing of Ocular Hypertension medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

California

Artesia : Kenneth Sall, M.D. Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Artesia : Artesia Clinical Site - Site 02

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Costa Mesa : Costa Mesa Clinical Site

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Inglewood : United Medical Research Institute Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Inglewood : Inglewood Clinical Site - Site 03

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

View More »

La Jolla : University of California San Diego

BOL-303259-X With Timolol 0.5% in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Newport Beach : Aesthetic Eye Care Institute Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Newport Beach : Newport Beach (satellite site)

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Petaluma : Bacharach practice Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Petaluma : Petaluma Clinical Site - Site 05

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Poway : Centre For Health Care Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

San Francisco : Glaucoma Center of San Francisco

The Efficacy of Selective Laser Trabeculoplasty

Santa Ana : Santa Ana (satellite site)

Single and Multiple Dose Escalation and Two-sequence Crossover Study of ONO-9054 in Patients With Ocular Hypertension or Mild Open-angle Glaucoma

Connecticut

New Haven : New Haven Clinical Site - Site 01

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Georgia

Atlanta : Atlanta Clinical Site - Site 04

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Morrow : Clayton Eye Center Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Roswell : Coastal Research Associates, LLC Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Kansas

Shawnee Mission : Bradley Kwapiszeski, MD Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Kentucky

Lexington : Univ of Ky

Safety Study of Latanoprost Slow Release Insert

Lexington : University of Kentucky

Safety Study of Latanoprost Slow Release Insert

Louisville : Taustine Eye Center Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Maryland

Baltimore : Alan L Robin, M.D. Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Havre de Grace : Seidenberg Protzko Eye Associates Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Michigan

St Joseph : Great Lakes Eye Care Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

New York

Rochester : Rochester Ophthalmological Group Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Rochester : Bausch & Lomb Inc.

Comparing Safety and Efficacy of BOL-303259-X With Timolol Maleate in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Rochester : Bausch & Lomb Inc.

Comparing the Safety and Efficacy of BOL-303259-X Ophthalmic Solution With Timolol Maleate Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension

Rochester :

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

North Carolina

Belmont : Charlotte Eye Ear Nose & Throat Associates, P.A. Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

High Point : High Point Clinical Site - Site 06

Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma

Oklahoma

Tulsa : The Eye Institute Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Texas

Austin : Texan Eye Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations

An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN®

Fort Worth : Contact Alcon Call Center for Trial Locations

Efficacy of Changing to Travatan From Prior Therapy

Fort Worth : Contact Alcon Call Center at 1-888-451-3937 for Trial Locations

Pharmacokinetic and Safety Study of Travoprost 0.004% in Pediatric Glaucoma Patients

San Antonio : Medical Center Ophth. Associates Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Utah

Salt Lake City : Stacy R. Smith, M.D. Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Virginia

Norfolk : Virginia Eye Consultants Updated

A Study Assessing PG286 Ophthalmic Solution, 0.5% Compared to Its Individual Components for 28 Days

Armenia

Yerevan : S.V. Malayan Ophthalmological Center

Subjects With Open-angle Glaucoma, Pseudoexfoliative Glaucoma, or Ocular Hypertension Naïve to Medical and Surgical Therapy, Treated With Two Trabecular Micro-bypass Stents (iStent Inject) or Travoprost

Australia

Fitzroy :

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Austria

Vienna :

A Study of Lumigan® 0.01% in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

Belgium

Edegem : Universitair Ziekenhuis Antwerpen, Dienst Oftalmologie

Long-Term Non-Interventional Latanoprost Study

Leuven : Universitair Ziekenhuis Leuven - Campus Sint-Raphaël

Long-Term Non-Interventional Latanoprost Study

Brazil

São Paulo :

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Canada

Vancouver :

Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction

Vaughan :

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

China

Beijing :

A Study of Quantitative Assessments of Angle Width in Chinese Patients With Open-angle Glaucoma and/or Ocular Hypertension

Colombia

Bogotá :

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Czech Republic

Brno : Fakultni nemocnice Brno

Long-Term Non-Interventional Latanoprost Study

Praha 5 : Fakultni nemocnice v Motole

Long-Term Non-Interventional Latanoprost Study

Denmark

Glostrup : Glostrup Hospital, Oegenafdelingen

Long-Term Non-Interventional Latanoprost Study

Estonia

Tallin : East Tallin Central Hospital

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Tallin : Eye Clinic Dr. Krista Turman

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Finland

Kuopio : Eye clinic, University Hospital of Kuopio

Tafluprost-Timolol Preservative-free Fixed Dose Combination (FDC) Superiority Study Against Monotherapies

Tampere : FinnMedi Oy, Clinical Trial Center

The Effects of Preservative-free Prostaglandin Eye Drops in Sign and Symptoms on the Eyes of Patients With Glaucoma

France

Amiens : CHU d'Amiens -Centre Saint Victor

Long-Term Non-Interventional Latanoprost Study

Lille Cedex : Hopital Claude Huriez

Long-Term Non-Interventional Latanoprost Study

Lyon :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Germany

Dresden :

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Freiburg : Universitaetsklinikum Freiburg

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Giessen : Universitaetsklinikum Giessen

Long-Term Non-Interventional Latanoprost Study

Hamburg : Universitaetsklinikum Hamburg-Eppendorf

Long-Term Non-Interventional Latanoprost Study

Köln : Uniklinik Köln

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

View More »

Mainz : Universitaetsklinikum Mainz

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Mainz : Universitaetsklinikum Mainz

Long-Term Non-Interventional Latanoprost Study

Mainz :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Greece

Thessaloniki : University General Hospital of Thessaloniki AHEPA

Long-Term Non-Interventional Latanoprost Study

India

Gurgaon : MSD Pharmaceuticals Pvt. Ltd

Preservative-Free Tafluprost (MK-2452) for the Treatment of Open-Angle Glaucoma or Ocular Hypertension (MK-2452-002 AM1)

Israel

Haifa : Bnei Zion Medical Center

Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure

Petach Tikva :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Tel Aviv :

Safety and Efficacy of a New Ophthalmic Formulation of Bimatoprost in Patients With Open Angle Glaucoma and Ocular Hypertension

Italy

Catania : Azienda Ospedaliero Univ.

Long-Term Non-Interventional Latanoprost Study

Fiumicino (Roma) : Ospedale Pediatrico Bambino Gesu

Long-Term Non-Interventional Latanoprost Study

Genova : Istituto Giannina Gaslini, Divisione di Oculistica

Long-Term Non-Interventional Latanoprost Study

Milano : Unita' Operativa di Oculistica Pediatrica, Azienda Ospedaliera Ospedale Niguarda Ca'Grande

Long-Term Non-Interventional Latanoprost Study

Milano :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Mexico

Mexico City :

Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Netherlands

Amsterdam :

A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension

Peru

Miraflores : Óptima Visión

Long-Term Non-Interventional Latanoprost Study

Poland

Gdańsk :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Portugal

Slovakia

Bratislava : Detska Fakultna nemocnica s poliklinikou Bratislava

Long-Term Non-Interventional Latanoprost Study

Spain

Barcelona : Institut Català de Retina

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Esplugues de Llobregat : Hospital Sant Joan de Deu

Long-Term Non-Interventional Latanoprost Study

Madrid : Hospital Universitario 12 de Octubre

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Madrid : Hospital Universitario Ramón y Cajal

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Madrid : Hospital Universitario Clínico San Carlos

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

View More »

Madrid : Hospital Clinico San Carlos

Long-Term Non-Interventional Latanoprost Study

Pamplona : Clinica Universidad Navarra

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Sevilla : Hospital Virgen Del Rocio

Long-Term Non-Interventional Latanoprost Study

Torrevieja :

Long-Term Safety of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Valladolid : Instituto de Oftalmobiología Aplicada

Dose Finding Clinical Trial With SYL040012 to Evaluate the Tolerability and Effect on Intraocular Pressure in Subjects With Ocular Hypertension or Open Angle Glaucoma

Zaragoza : Hospital Universitario Miguel Servet

Long-Term Non-Interventional Latanoprost Study

Sweden

Uppsala : Akademiska Sjukhuset

Long-Term Non-Interventional Latanoprost Study

Vasteras : Ogonkliniken, Centrallasarett

Long-Term Non-Interventional Latanoprost Study

United Kingdom

Birmingham : Birmingham and Midland Eye Centre, Consultant Ophthalmologist

Long-Term Non-Interventional Latanoprost Study

London : Richard Desmond Childrens Eye Centre

Long-Term Non-Interventional Latanoprost Study